Remove 2022 Remove Physicians Remove Specialization
article thumbnail

Medical Devices Are Evolving Toward Specialized Solutions

MedCity News

As medical devices evolve and become more sophisticated, we are seeing a trend toward specialization. Building customized solutions for specialized disease states creates a nimbleness to respond to new conditions and develop a platform uniquely suited for that condition. It will become commonplace to see devices that break new ground.

article thumbnail

Lazurite is Recognized in the 2022 Medical Device Network Excellence Awards & Rankings for its ArthroFree™ System

Legacy MEDSearch

The company hit an important milestone in March 2022 when it received U.S. This was followed in September 2022 by another important step as the first surgery using the system was performed by orthopedic surgeon Laith M. Food and Drug Administration market clearance for the ArthroFree System. Lazurite is located in Cleveland, OH (est.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why

PM360

2 and over a million actively licensed physicians 3 are available to prescribe them? Pharma companies have shifted their focus to specialized conditions such as multiple sclerosis and ulcerative colitis. 4 The drug market for specialized conditions is small, but it’s where pharma companies can generate the most revenue.

article thumbnail

OIG’s Call for Increased Oversight of Remote Patient Monitoring Misses the Mark

Nixon Gwilt Law

The OIG Report: Key Findings The OIG indicates that this report was triggered in part by the rapid increase in Medicare claims for RPM between 2019 and 2022, with the number of enrollees using RPM services increasing more than tenfold during that time. The significant increase in claims from 2019 to 2022 is not a cause for concern.

article thumbnail

OIG’s Call for Increased Oversight of Remote Patient Monitoring Misses the Mark

Nixon Gwilt Law

The OIG Report: Key Findings The OIG indicates that this report was triggered in part by the rapid increase in Medicare claims for RPM between 2019 and 2022, with the number of enrollees using RPM services increasing more than tenfold during that time. The significant increase in claims from 2019 to 2022 is not a cause for concern.

article thumbnail

Digital health investors getting choosier as sector matures

pharmaphorum

Despite the well-documented retreat from record levels of funding for digital health ventures during the pandemic, the sector remains resilient with regulatory filings and partnering activity well up in 2022 on the previous year. billion) led by a $300 million Series E for connected kidney care specialist Somatus.

article thumbnail

Preventive Care Awareness and Access is Lagging for LGBTQ+ Patients—But Pharma Can Help

PM360

Physicians Need More Education. As healthcare marketers, we can support physicians in this effort by raising awareness of the LGBTQ+ screening gap and by providing tactical support,” she says. “For There is a special kind of access to consider that is specific to the LGBTQ+ community,” Briggs says.